Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease
- 10 April 2000
- journal article
- Published by Elsevier
- Vol. 76 (2) , 347-354
- https://doi.org/10.1016/s0169-328x(00)00023-1
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Method for Quantitation of Low-Abundance Nerve Growth Factor mRNA Expression in Human Nervous Tissue Using Competitive Reverse Transcription Polymerase Chain ReactionDNA and Cell Biology, 1996
- Differential Actions of Neurotrophins in the Locus Coeruleus and Basal ForebrainExperimental Neurology, 1993
- Activation of basal forebrain cholinergic neurons differentially regulates brain-derived neurotrophic factor mRNA expression in different projection areasNeuroscience Letters, 1992
- Is the pattern of nerve cell loss in ageing and Alzheimer's disease a real, or only an apparent, selectivity?Neurobiology of Aging, 1991
- Widespread Expression of BDNF But Not NT3 by Target Areas of Basal Forebrain Cholinergic NeuronsScience, 1990
- Localization of brain-derived neurotrophic factor mRNA to neurons in the brain by in situ hybridizationExperimental Neurology, 1990
- Placodal sensory neurons in culture: Nodose ganglion neurons are unresponsive to NGF, lack NGF receptors but are supported by a liver-derived neurotrophic factorDevelopmental Biology, 1985
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- The anatomy of the CNS cholinergic neuronsTrends in Neurosciences, 1984
- Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal ForebrainScience, 1982